OS Therapies Inc - Common Stock, par value $0.001 per share (OSTX)
CUSIP: 68764Y207
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 31,500,824
- Total 13F shares
- 389,286
- Share change
- +244,282
- Total reported value
- $599,294
- Price per share
- $1.54
- Number of holders
- 6
- Value change
- +$293,725
- Number of buys
- 4
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 68764Y207?
CUSIP 68764Y207 identifies OSTX - OS Therapies Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68764Y207:
Top shareholders of OSTX - OS Therapies Inc - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Colin Goddard |
3/4/5
|
Director |
—
mixed-class rows
|
625,179
mixed-class rows
|
$1,516,581 | — | 31 Dec 2024 | |
| CM Management, LLC |
13F
|
Company |
0.35%
|
110,044
|
$470,988 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
29,836
|
$127,698 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.01%
|
3,143
|
$13,452 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
1,881
|
$8,051 | — | 31 Dec 2024 | |
| ARMSTRONG ADVISORY GROUP, INC |
13F
|
Company |
0%
|
100
|
$428 | — | 31 Dec 2024 |
Institutional Holders of OS Therapies Inc - Common Stock, par value $0.001 per share (OSTX) as of Q1 2025
As of 31 Mar 2025,
OS Therapies Inc - Common Stock, par value $0.001 per share (OSTX) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
389,286 shares.
The largest 6 holders included
CM Management, LLC, BlackRock, Inc., INGALLS & SNYDER LLC, STIFEL FINANCIAL CORP, ARMSTRONG ADVISORY GROUP, INC, and MORGAN STANLEY.
This page lists
6
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
5
Q1 2025 holders
6
Holder diff
1
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.